How GLP 1 Can Help in Treating Addiction Disorders | remarkable ideas

By Alan

Five things to know about GLP

How GLP 1 Can Help in Treating Addiction Disorders
How GLP 1 Can Help in Treating Addiction Disorders

The Food and Drug Administration has approved GLP-1 medications for treating type 2 diabetes and obesity. Some doctors are prescribing these drugs off-label for a variety of addictive disorders . Research is under way on the effectiveness of treating addiction with these medications, and some initial studies have shown promising results.

The Ultimate Guide to GLP 1 Peptides What They Are How They Work
The Ultimate Guide to GLP 1 Peptides What They Are How They Work

A popular class of therapies for treating diabetes and obesity may also have the potential to treat alcohol and drug addiction , according to a new paper published in the Journal of the Endocrine Society. The therapies, known as Glucagon-Like Peptide-1 Receptor Agonists ( GLP -1RAs), present an encouraging approach to treating alcohol and other substance use disorders . "Early research in both ...

Can GLP

GLP 1 and Cancer ️
GLP 1 and Cancer ️

Clinical trials suggest Ozempic and Other GLP-1s may treat alcohol, opioid and nicotine addiction by rewiring the brain's reward system. Learn about the science, risks and off-label use.

The GLP-1 class of diabetes and obesity drugs show promise in treating and preventing all substance use disorders in a new study.

Women see greater weight loss but more side effects on GLP 1s
Women see greater weight loss but more side effects on GLP 1s

The potential role of GLP

These findings imply that different GLP-1 receptor agonists might have differential efficacy across various substance use disorders , being more effective in treating alcohol and nicotine addiction but less so for opioid addiction .

Glucagon‐like peptide 1 ( GLP‐1 ) is released in the small intestine, promotes blood glucose homeostasis, slows gastric emptying and reduces appetite. GLP‐1 receptor agonists approved for treating Type 2 diabetes mellitus and obesity have received attention as a potential anti‐addiction treatment.

GLP 1 Practical Guides Dosing Side Effects Stopping Plateaus
GLP 1 Practical Guides Dosing Side Effects Stopping Plateaus

Five things to know about GLP

The Food and Drug Administration has approved GLP-1 medications for treating type 2 diabetes and obesity. Some doctors are prescribing these drugs off-label for a variety of addictive disorders .

Researchers have discovered that drugs like Ozempic for diabetes and obesity also improve alcohol use disorders and other addictions . This is a stunning gut-brain breakthrough.

GLP 1 Medication Complete Guide to Benefits Uses Side Effects
GLP 1 Medication Complete Guide to Benefits Uses Side Effects

Key Details About How Glp 1 Can Help In Treating Addiction Disorders

May 12, 2026 GLP-1 plus therapy can reduce heavy drinking At a Glance People with alcohol use disorder and obesity drank less when treated with a GLP-1 drug in addition to cognitive behavioral therapy. Findings from the clinical trial suggest GLP-1s could help to treat alcohol use disorder .

People with eating disorders are taking GLP 1s and doctors are alarmed
People with eating disorders are taking GLP 1s and doctors are alarmed
History of GLP 1 From Discovery to Revolutionary Treatment
History of GLP 1 From Discovery to Revolutionary Treatment
WHO Issues First Ever GLP 1 Drug Guidelines for Obesity What Cochrane
WHO Issues First Ever GLP 1 Drug Guidelines for Obesity What Cochrane
GLP 1 Medications May Help Slow the Spread of Obesity Related Cancers
GLP 1 Medications May Help Slow the Spread of Obesity Related Cancers
How To Manage GLP 1 Side Effects
How To Manage GLP 1 Side Effects
GLP 1 programs the neurovascular landscape Cell Metabolism
GLP 1 programs the neurovascular landscape Cell Metabolism
A Guide to GLP 1 Receptor Agonists for Weight Loss in Singapore
A Guide to GLP 1 Receptor Agonists for Weight Loss in Singapore

GLP-1 receptor agonists aren't just for diabetes or obesity—they may treat cannabis abuse disorder . GLP-1 drugs may target an earlier step in the drug attachment, addiction , and relapse cycle.